Total Funding
51
66
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
125962
Revive Therapeutics is focused on the research, development and commercialization ofnovel therapies and technologies company.
Michael Frank: Founder&CEO
Doug Cowart: CEO
About the Company
Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) (FSE: 31R) is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets by identifying and investigating potential therapies targeting the endocannabinoid system, such as cannabinoids, that may
be repurposed for new indications, be delivered in a different way, combined with existing drugs, or be developed as new chemical entities.
